when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Testosterone Upsher-Smith · news · pharmadog

← back to Testosterone Upsher-Smith

News mentioning Testosterone Upsher-Smith

26 stories

12dOpinion: Former FDA commissioners: Heidi Overton has an opportunity to strengthen the FDAstat

16dOpinion: More young men are coming to me for plastic surgery. The way I think about them has changedstat

17dThis Week at FDA: Overton nomination hearing, FDA’s hiring challenges, and moreraps

Sep 4, 26Disabled workers at greater risk of losing health insurancestat

Jul 24, 26A new, separate outbreak of the diarrhea-causing parasitestat

Jul 23, 26Expect a clash at today’s FDA peptide panelstat

Jul 23, 26Opinion: New billing codes likely to raise maternity care costsstat

Jul 23, 26Opinion: Good riddance to bundled ‘global’ maternal care billingstat

Jul 22, 26Job dissatisfaction and health care access uncertainty grows in the U.S., new study findsstat

Jul 22, 26Opinion: STAT+: Hospitals’ AI may be drifting. Who’s watching?stat

Jul 22, 26Opinion: STAT+: I’m a cardiologist. I’m not sure the new cholesterol drug enlicitide is a game-changerstat

Jul 21, 26Opinion: Pete Hegseth, ‘The Odyssey,’ and the testosterone mythstat

Jul 21, 26A renewed push from the right against abortion pillsstat

Jul 21, 26Opinion: How a controversial rule could hurt the NIH’s ability to manage riskstat

Jul 21, 26Opinion: Science and the public are learning the wrong lessons from Covidstat

Jul 20, 26HHS vaccine committee quietly gets new charterstat

Jul 20, 26STAT+: Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputerstat

Jul 20, 26Opinion: My husband’s suicide shows there’s something very wrong with the U.S. insurance industrystat

Jul 20, 26STAT+: Telemedicine company touted by Novo Nordisk stressed profits over patient safety, ex-workers saystat

Jul 20, 26Opinion: It’s time to treat pandemics as threats to national securitystat

Jul 18, 26Opinion: Beware the unintended consequences of testosterone screening for military servicemembersstat

Jul 17, 26Lettuce at Taco Bell in five states confirmed as a source of diarrhea-causing parasitestat

Jul 17, 26Who can access testosterone hormone medication in the U.S.?stat

Jul 16, 26Pete Hegseth’s announcement of annual testosterone screenings for service members divides medical expertsstat

Jun 4, 26Male puberty is understudied — but when it starts may predict long-term health risksstat

Dec 22, 25Fierce Biotech Fundraising Tracker '26: TriGemX tacks on $94M; AnaCardio adds $71Mfiercebiotech